Patient Reimbursement Support Services
Corcept is committed to every Cushing's syndrome patient whose doctor prescribes Korlym® receiving it. We have an active program of reimbursement services and assistance programs designed to help Korlym patients. These programs include:
- Coverage and Reimbursement services, including scheduling of shipments
- Copay support of up to $5000 per year for qualifying patients
- Free drug through our Patient Assistance Program for uninsured patients
We also provide referrals to independent non-profit organizations that help patients find insurance and support copay costs for patients.
These programs ensure that most patients have access to Korlym regardless of their ability to pay. For more information about Korlym support programs go to http://www.korlym.com/patient/resources.php
Indications and Usage
Korlym (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery.
Important Limitations of Use
Do not use for the treatment of type 2 diabetes mellitus unrelated to endogenous Cushing's syndrome